Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
2018 · Leukemia · 311 citations
https://doi.org/10.1038/s41375-018-0180-3
T
Thomas Köhnke
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
213
Papers
2.5K
Citations
24
h-index
30
i10-index
Thomas Köhnke is an academic researcher. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Cancer Research and Treatments & Virus-based gene therapy research. The author has an h-index of 24, co-authored 182 publications.
ORCID: 0000-0001-7454-6282Papers by this author
worksBlockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
2015 · Leukemia · 239 citations
https://doi.org/10.1038/leu.2015.214
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
2018 · Leukemia · 137 citations
https://doi.org/10.1038/s41375-018-0034-z
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
2022 · Cancer Discovery · 56 citations
https://doi.org/10.1158/2159-8290.cd-21-0218
The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells
2021 · Nature Communications · 29 citations
https://doi.org/10.1038/s41467-020-20792-y
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML
2022 · Biomarker Research · 19 citations
https://doi.org/10.1186/s40364-022-00390-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat